ℹ️
🇬🇧
Search
Search for people relevant for "high-dose chemotherapy"
high-dose chemotherapy
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Tomáš Kozák Ph.D.
Academic staff at Third Faculty of Medicine
3 classes
138 publications
Classes
class
Hematology and Oncology
+1
C3VL008 |
Third Faculty of Medicine
class
ERASMUS - Hematology and Oncology
CERA3P0047 |
Third Faculty of Medicine
Publications
publication
Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis
2001 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis
2000 |
Central Library of Charles University
publication
Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions
2024 |
Third Faculty of Medicine, Central Library of Charles University
publication
Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case report
2023 |
Third Faculty of Medicine
publication
Recommendations of the Czech Society of Haematology for the diagnosis and treatment of immune thrombocytopenia in adults
2023 |
Central Library of Charles University
publication
Circulating tumor DNA in Hodgkin lymphoma
2022 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group
2021 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University
Load more publications (128)
Loading network view...